Business

India’s Q1 pharma exports up 6.8% to $8.1bn; U.S. remains largest export destination

NAFTA (North American Free Trade Agreement), Europe, Africa and Latin America and the Caribbean (LAC) continued to be the key destinations region-wise, accounting for nearly 75% of the export

· 8/13/2026, 3:26:37 PM· 2 min read
India’s Q1 pharma exports up 6.8% to $8.1bn; U.S. remains largest export destination
NAFTA (North American Free Trade Agreement), Europe, Africa and Latin America and the Caribbean (LAC) continued to be the key destinations region-wise, accounting for nearly 75% of the export
Read original story

Related stories